Peripheral neuropeptide Y Y1 receptors regulate lipid oxidation and fat accretion (Q61974730)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19918245%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

title

Peripheral neuropeptide Y Y1 receptors regulate lipid oxidation and fat accretion (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19918245%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19918245%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Nigel Turner

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19918245%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Amy D Nguyen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19918245%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Nicola J Lee

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19918245%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Ernie Yulyaningsih

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19918245%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

author name string

L Zhang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19918245%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

R F Enriquez

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19918245%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

S J Riepler

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19918245%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

S Lin

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19918245%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Y C Shi

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19918245%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

K Slack

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19918245%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

P A Baldock

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19918245%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

H Herzog

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19918245%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

A Sainsbury

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19918245%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

language of work or name

English

0 references

publication date

17 November 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19918245%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Obesity

12 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19918245%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19918245%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19918245%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

page(s)

357-373

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19918245%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/ijo.2009.232

12 February 2020

exact match

0 references

cites work

Chronic administration of neuropeptide Y into the lateral ventricle of C57BL/6J male mice produces an obesity syndrome including hyperphagia, hyperleptinemia, insulin resistance, and hypogonadism.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.232

7 January 2021

Chronic central neuropeptide Y infusion in normal rats: status of the hypothalamo-pituitary-adrenal axis, and vagal mediation of hyperinsulinaemia.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.232

7 January 2021

Combined deletion of Y1, Y2, and Y4 receptors prevents hypothalamic neuropeptide Y overexpression-induced hyperinsulinemia despite persistence of hyperphagia and obesity.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.232

7 January 2021

Neuropeptide Y chronically injected into the hypothalamus: a powerful neurochemical inducer of hyperphagia and obesity.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.232

7 January 2021

Thermoregulatory effect of intracerebral injections of neuropeptide Y in rats at different environmental temperatures.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.232

7 January 2021

Dissociated feeding and hypothermic effects of neuropeptide Y in the paraventricular and perifornical hypothalamus

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.232

7 January 2021

Intracerebroventricular administration of neuropeptide Y to normal rats has divergent effects on glucose utilization by adipose tissue and skeletal muscle.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.232

7 January 2021

Chronic intracerebroventricular neuropeptide-Y administration to normal rats mimics hormonal and metabolic changes of obesity

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.232

7 January 2021

Metabolic effects of neuropeptide Y injections into the paraventricular nucleus of the hypothalamus

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.232

7 January 2021

Hypothalamic paraventricular nucleus injections of urocortin alter food intake and respiratory quotient

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.232

7 January 2021

Energy metabolic profile of mice after chronic activation of central NPY Y1, Y2, or Y5 receptors.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.232

7 January 2021

Y-receptor subtypes--how many more?

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.232

7 January 2021

A typical Y1 receptor regulates feeding behaviors: effects of a potent and selective Y1 antagonist, J-115814.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.232

7 January 2021

The novel neuropeptide Y Y(1) receptor antagonist J-104870: a potent feeding suppressant with oral bioavailability

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.232

7 January 2021

Characterisation of the neuropeptide Y receptor that mediates feeding in the rat: a role for the Y5 receptor?

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.232

7 January 2021

Pharmacological characterization and appetite suppressive properties of BMS-193885, a novel and selective neuropeptide Y(1) receptor antagonist

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.232

7 January 2021

Y2Y4 Receptor Double Knockout Protects Against Obesity Due to a High-Fat Diet or Y1 Receptor Deficiency in Mice

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.232

7 January 2021

Novel role of Y1 receptors in the coordinated regulation of bone and energy homeostasis.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.232

7 January 2021

Cardiovascular response, feeding behavior and locomotor activity in mice lacking the NPY Y1 receptor

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.232

7 January 2021

Obesity and mild hyperinsulinemia found in neuropeptide Y-Y1 receptor-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.232

7 January 2021

Changes in energy expenditure resulting from altered body weight

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.232

7 January 2021

Recent developments in our understanding of the physiological role of PP-fold peptide receptor subtypes.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.232

7 January 2021

Identification and distribution of mRNA encoding the Y1, Y2, Y4, and Y5 receptors for peptides of the PP-fold family in the rat intestine and colon.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.232

7 January 2021

Characterization of NPY receptors controlling lipolysis and leptin secretion in human adipocytes

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.232

7 January 2021

Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.232

7 January 2021

NPY Y1 receptor antagonist prevents NPY-induced torpor-like hypothermia in cold-acclimated Siberian hamsters

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.232

7 January 2021

ICV NPY Y1 receptor agonist but not Y5 agonist induces torpor-like hypothermia in cold-acclimated Siberian hamsters.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.232

7 January 2021

Differential regulation of neuropeptide Y receptors in the brains of NPY knock-out mice

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.232

7 January 2021

Y1-receptors regulate the expression of Y2-receptors in distinct mouse forebrain areas.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.232

7 January 2021

Compensatory changes in [125I]-PYY binding in Y receptor knockout mice suggest the potential existence of further Y receptor(s)

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.232

7 January 2021

Role of the Y5 neuropeptide Y receptor in feeding and obesity

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.232

7 January 2021

Neuropeptide Y is neuroproliferative for post-natal hippocampal precursor cells

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.232

7 January 2021

Inducible gene targeting in mice

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.232

7 January 2021

The theoretical bases of indirect calorimetry: a review

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.232

7 January 2021

Calculation of substrate oxidation rates in vivo from gaseous exchange.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.232

7 January 2021

Excess Lipid Availability Increases Mitochondrial Fatty Acid Oxidative Capacity in Muscle

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.232

7 January 2021

Casitas b-lineage lymphoma-deficient mice are protected against high-fat diet-induced obesity and insulin resistance

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.232

7 January 2021

Carnitine palmitoyltransferase and carnitine octanoyltransferase activities in liver, kidney cortex, adipocyte, lactating mammary gland, skeletal muscle and heart

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.232

7 January 2021

Observations on the affinity for carnitine, and malonyl-CoA sensitivity, of carnitine palmitoyltransferase I in animal and human tissues. Demonstration of the presence of malonyl-CoA in non-hepatic tissues of the rat

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.232

7 January 2021

Metabolic control through the PGC-1 family of transcription coactivators

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.232

7 January 2021

High-affinity neuropeptide Y receptor antagonists

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.232

7 January 2021

Modulation of central leptin sensitivity and energy balance in a rat model of diet-induced obesity

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.232

7 January 2021

Skeletal muscle oxidative capacity in rats fed high-fat diet

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.232

7 January 2021

Role of nonexercise activity thermogenesis in resistance to fat gain in humans.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.232

7 January 2021

Beneficial effects of subcutaneous fat transplantation on metabolism

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.232

7 January 2021

Studies of regional adipose transplantation reveal a unique and beneficial interaction between subcutaneous adipose tissue and the intra-abdominal compartment

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.232

7 January 2021

Determinants of 24-hour energy expenditure in man. Methods and results using a respiratory chamber

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.232

7 January 2021

Successful long-term weight maintenance: a 2-year follow-up

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.232

7 January 2021

Predictors of long-term weight maintenance

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.232

7 January 2021

Metabolically active components of fat free mass and resting energy expenditure in nonobese adults

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.232

7 January 2021

Hepatic energy and substrate metabolism: a possible metabolic basis for early nutritional support in cirrhotic patients

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.232

7 January 2021

Metabolism and force in hypertrophic smooth muscle from rat urinary bladder

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.232

7 January 2021

Regulation of fatty acid oxidation in skeletal muscle

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.232

7 January 2021

Overexpression of carnitine palmitoyltransferase I in skeletal muscle in vivo increases fatty acid oxidation and reduces triacylglycerol esterification

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.232

7 January 2021

Mutations in the medium chain acyl-CoA dehydrogenase (MCAD) gene

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.232

7 January 2021

Importance of NPY Y1 receptor-mediated pathways: assessment using NPY Y1 receptor knockouts

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.232

7 January 2021

Daily, intermittent intravenous infusion of peptide YY(3-36) reduces daily food intake and adiposity in rats

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.232

7 January 2021

The neuropeptide Y Y1 receptor regulates leptin-mediated control of energy homeostasis and reproductive functions

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.232

7 January 2021

The neuropeptide Y Y1 receptor mediates NPY-induced inhibition of the gonadotrope axis under poor metabolic conditions.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.232

7 January 2021

Estrogen regulation of adiposity and fuel partitioning. Evidence of genomic and non-genomic regulation of lipogenic and oxidative pathways

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.232

7 January 2021

Estrogen increases locomotor activity in mice through estrogen receptor alpha: specificity for the type of activity

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.232

7 January 2021

Effects of estrogen replacement therapy on abdominal fat compartments as related to glucose and lipid metabolism in early postmenopausal women

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.232

7 January 2021

Effects of testosterone on body composition of the aging male

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.232

7 January 2021

Menopause, energy expenditure, and body composition

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.232

7 January 2021

Contribution of age and declining androgen levels to features of the metabolic syndrome in men.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.232

7 January 2021

Effect of Y1 receptor deficiency on motor activity, exploration, and anxiety.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.232

7 January 2021

Thematic review series: adipocyte biology. Sympathetic and sensory innervation of white adipose tissue

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.232

7 January 2021

Mechanisms regulating adipocyte lipolysis

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.232

7 January 2021

Hypotension and reduced catecholamines in neuropeptide Y transgenic rats

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.232

7 January 2021

The non-peptide neuropeptide Y Y1 receptor antagonist BIBP3226 blocks the [Leu31,Pro34]neuropeptide Y-induced modulation of alpha 2-adrenoceptors in the nucleus tractus solitarii of the rat.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.232

7 January 2021

Ultrastructural localization of neuropeptide Y Y1 receptors in the rat medial nucleus tractus solitarius: relationships with neuropeptide Y or catecholamine neurons

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.232

7 January 2021

Sympathetic innervation of white adipose tissue and its regulation of fat cell number.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.232

7 January 2021

Tissue-specific regulation of fat cell lipolysis by NPY in 6-OHDA-treated rats.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.232

7 January 2021

Neuropeptides, including neuropeptide Y and melanocortins, mediate lipolysis in murine adipocytes

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.232

7 January 2021

Neuropeptide Y and peptide YY inhibit lipolysis in human and dog fat cells through a pertussis toxin-sensitive G protein

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.232

7 January 2021

Receptors involved in nerve-mediated vasoconstriction in small arteries of the rat hepatic mesentery

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.232

7 January 2021

Neuropeptide Y immunoreactivity in the mammalian liver: pattern of innervation and coexistence with tyrosine hydroxylase immunoreactivity

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.232

7 January 2021

Drug treatments for obesity: orlistat, sibutramine, and rimonabant.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.232

7 January 2021

Identifiers

DOI

10.1038/IJO.2009.232

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19918245%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

12 February 2020

0 references

1 reference